JPH09507499A - ５−ニトロイミダゾール誘導体の微粒剤 - Google Patents

５−ニトロイミダゾール誘導体の微粒剤

Info

Publication number
JPH09507499A
JPH09507499A JP7518878A JP51887895A JPH09507499A JP H09507499 A JPH09507499 A JP H09507499A JP 7518878 A JP7518878 A JP 7518878A JP 51887895 A JP51887895 A JP 51887895A JP H09507499 A JPH09507499 A JP H09507499A
Authority
JP
Japan
Prior art keywords
microgranules
form according
galenical form
sustained release
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7518878A
Other languages
English (en)
Japanese (ja)
Inventor
ルデュック，ジェラール
デブレジャ，パトリス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of JPH09507499A publication Critical patent/JPH09507499A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP7518878A 1994-01-14 1995-01-12 ５−ニトロイミダゾール誘導体の微粒剤 Pending JPH09507499A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
FR94/00394 1994-01-14
PCT/FR1995/000039 WO1995019168A1 (fr) 1994-01-14 1995-01-12 Microgranules de derives de 5-nitro imidazole

Publications (1)

Publication Number Publication Date
JPH09507499A true JPH09507499A (ja) 1997-07-29

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7518878A Pending JPH09507499A (ja) 1994-01-14 1995-01-12 ５−ニトロイミダゾール誘導体の微粒剤

Country Status (19)

Country Link
JP (1) JPH09507499A (pt)
KR (1) KR100320140B1 (pt)
CN (1) CN1088357C (pt)
AT (1) ATE187068T1 (pt)
AU (1) AU705570B2 (pt)
BR (1) BR9506507A (pt)
CZ (1) CZ286080B6 (pt)
DE (1) DE69513632T2 (pt)
DK (1) DK0739201T3 (pt)
ES (1) ES2139883T3 (pt)
MA (1) MA23429A1 (pt)
MX (1) MX9602772A (pt)
NZ (1) NZ279238A (pt)
OA (1) OA10583A (pt)
PL (1) PL178424B1 (pt)
PT (1) PT739201E (pt)
RU (1) RU2152212C1 (pt)
SK (1) SK282066B6 (pt)
UA (1) UA28031C2 (pt)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003192579A (ja) * 2001-10-17 2003-07-09 Takeda Chem Ind Ltd 酸に不安定な薬物の高含量顆粒
JP2017526697A (ja) * 2014-09-05 2017-09-14 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
WO1991017744A1 (en) * 1990-05-14 1991-11-28 Jernberg Gary R Surgical implant and method incorporating chemotherapeutic agents

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003192579A (ja) * 2001-10-17 2003-07-09 Takeda Chem Ind Ltd 酸に不安定な薬物の高含量顆粒
JP2017526697A (ja) * 2014-09-05 2017-09-14 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
US10849884B2 (en) 2014-09-05 2020-12-01 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis
US10857133B2 (en) 2014-09-05 2020-12-08 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis
JP2021042246A (ja) * 2014-09-05 2021-03-18 ルピン・インコーポレイテッド 細菌性膣炎の治療に使用するためのセクニダゾール
US11000507B2 (en) 2014-09-05 2021-05-11 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis
US11000508B2 (en) 2014-09-05 2021-05-11 Lupin Inc. Secnidazole for use in the treatment of trichomoniasis
US11020377B2 (en) 2014-09-05 2021-06-01 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis
US11324721B2 (en) 2014-09-05 2022-05-10 Lupin Inc. Secnidazole for use in the treatment of trichomoniasis
US11602522B2 (en) 2014-09-05 2023-03-14 Lupin Inc. Secnidazole for use in the treatment of sexually transmitted infection
US11684607B2 (en) 2014-09-05 2023-06-27 Lupin, Inc. Secnidazole for use in the treatment of bacterial vaginosis

Also Published As

Publication number Publication date
DE69513632T2 (de) 2000-04-06
OA10583A (en) 2002-07-10
MA23429A1 (fr) 1995-10-01
CN1138826A (zh) 1996-12-25
MX9602772A (es) 1997-05-31
DK0739201T3 (da) 2000-05-01
PL178424B1 (pl) 2000-04-28
CZ286080B6 (cs) 2000-01-12
DE69513632D1 (de) 2000-01-05
RU2152212C1 (ru) 2000-07-10
AU705570B2 (en) 1999-05-27
CN1088357C (zh) 2002-07-31
PT739201E (pt) 2000-05-31
NZ279238A (en) 1998-03-25
UA28031C2 (uk) 2000-10-16
BR9506507A (pt) 1997-09-09
CZ205596A3 (en) 1996-10-16
PL315530A1 (en) 1996-11-12
ES2139883T3 (es) 2000-02-16
SK282066B6 (sk) 2001-10-08
KR100320140B1 (ko) 2002-07-02
AU1580395A (en) 1995-08-01
ATE187068T1 (de) 1999-12-15
SK91496A3 (en) 1996-12-04

Similar Documents

Publication Publication Date Title
TW576743B (en) Extended release formulations of erythromycin derivatives
US20110064808A1 (en) Extended release formulation of levetiracetam
JP2002532425A (ja) 新規な医薬製剤
TWI483748B (zh) 含有氫嗎啡酮（ｈｙｄｒｏｍｏｒｐｈｏｎｅ）和納洛酮（ｎａｌｏｘｏｎｅ）之藥學組成物
JP2003534236A (ja) ニメスリドを含む制御放出組成物
CN102026627A (zh) 口腔崩解固体制剂
JP2000514830A (ja) 急速に放出し且つ味を隠蔽する医薬剤形
JP2002080398A (ja) ｐＨに依存する多相的な放出を伴う経口用の固体の薬学的組成物
JP2001106632A (ja) 緩下剤の効力を高める方法及び組成物
CN109893516A (zh) 用于治疗幽门螺杆菌的药物组合物
CA3077514C (en) Delayed release deferiprone tablets and methods of using the same
EP1581197A1 (en) Coating composition for taste masking coating and methods for their application and use
JP2001519782A (ja) 新規製剤
JPS63258809A (ja) 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
JP2004512298A (ja) 遅延及び持続放出製剤、及びそれを使用する方法
WO2005020961A1 (en) Pharmaceutical composition comprising anticonvulsant with taste mask coating
WO2005058282A1 (en) Double pellet formulation of proton pump inhibitors and clarithromycin for the treatment of gastrointestinal ulcer, and method for producing the same
WO2004024128A2 (en) Modified release ketoprofen dosage form
US5549911A (en) Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
CZ20032488A3 (cs) Gastroirezistentní soli ketokyselin a aminikyselin a jejich použití pro přípravu léků
JPH09507499A (ja) ５−ニトロイミダゾール誘導体の微粒剤
KR102568681B1 (ko) 네포팜을 포함하는 경구 붕해 약학 조성물 및 그 제조 방법
EP0739201B1 (fr) Microgranules de derives de 5-nitro imidazole
JP2004035535A (ja) 非ステロイド系抗炎症薬剤を含む経口医薬組成物及びその製造方法
JP2003523981A (ja) モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040323

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040623

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040809

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040924

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050301